The clinical utility of neuron-specific enolase serum levels as a biomarker for Merkel cell carcinoma.

Linde M. van Veenendaal,Eduardo Bertolli,Catharina M. Korse,W. Martin C. Klop,Margot E.T. Tesselaar,Alexander C.J. van Akkooi

The clinical utility of neuron-specific enolase serum levels as a biomarker for Merkel cell carcinoma.

2019

Linde M. van Veenendaal
Eduardo Bertolli
Catharina M. Korse
W. Martin C. Klop
Margot E.T. Tesselaar
Alexander C.J. van Akkooi

9570Background: To date no adequate biomarker for Merkel Cell carcinoma (MCC) has been identified. The introduction of immunotherapy (IT) for metastatic MCC increases the need for a biomarker. Seru...

Keywords:

Merkel cell carcinoma
Enolase
Pathology
Biomarker (medicine)
Medicine
Immunotherapy
Cancer research

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations